Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
Sustained Nano Systems Reports Positive In-Vitro Results Glaucoma TreatmentMarch 8, 2018
SUSTAINED NANO SYSTEMS ACHIEVES POSITIVE IN-VITRO RESULTS ON LONG TERM SUSTAINED DELIVERY OF LATANAPROST FOR GLAUCOMA TREATMENT. New York, NY – March 6, 2018 (NEWSFRONT MEDIA). Sustained Nano Systems, LLC (“SNS”), a biopharmaceutical company utilizing its platform technology of bio-resorbable nano and microparticles for long …
Learn More -
Chronus Pharmaceuticals Receives Phase I STTRFebruary 1, 2018
Chronus Pharmaceuticals has received a $299,172 Phase I Small Business Technology Transfer (STTR) award in partnership with the Department of Chemistry at Stony Brook University.
Learn More -
Winter 2018 NewsletterJanuary 30, 2018
The latest CFB Newsletter has been released – Catch up on client financings, newcos, expansions, and other happenings.
Learn More
Upcoming Events
No Events